Cancer of unknown primary: progress in the search for improved and rapid diagnosis leading toward superior patient outcomes.
about
Cancers of unknown primary origin: current perspectives and future therapeutic strategiesCancer of unknown primary sites: what radiologists need to know and what oncologists want to knowCarcinoma of unknown primary with gastrointestinal profile: immunohistochemistry and survival data for this favorable subset.Comparison of survival of patients with metastases from known versus unknown primaries: survival in metastatic cancer.Novel microRNA-based assay demonstrates 92% agreement with diagnosis based on clinicopathologic and management data in a cohort of patients with carcinoma of unknown primaryA second-generation microRNA-based assay for diagnosing tumor tissue origin.Hepatocellular carcinoma presenting as thoracic spinal canal metastasis with no clinical primary foci: A report of a rare case and review of the literatureMetastatic Adenocarcinoma of Unknown Origin Presenting as Small Bowel Perforation: A Case Report and Literature Review.Possibility of molecular targeting therapy for the treatment of cancer of unknown primary origin by analysis of intracellular signaling molecules.Age-Dependent Metastatic Spread and Survival: Cancer of Unknown Primary as a ModelCancer of unknown primary: a population-based analysis of temporal change and socioeconomic disparities.Germline genetics of cancer of unknown primary (CUP) and its specific subtypesA case study of an integrative genomic and experimental therapeutic approach for rare tumors: identification of vulnerabilities in a pediatric poorly differentiated carcinoma.A multicenter study directly comparing the diagnostic accuracy of gene expression profiling and immunohistochemistry for primary site identification in metastatic tumors.Differentiation of cancer cell origin and molecular subtype by plasma membrane N-glycan profiling.Overview of various techniques/platforms with critical evaluation of each.Transcriptome Profiling in Human Diseases: New Advances and PerspectivesDetection of cancer cells using triplex DNA molecular beacons based on expression of enhanced green fluorescent protein (eGFP).Cost-effectiveness of using a gene expression profiling test to aid in identifying the primary tumour in patients with cancer of unknown primary.The epidemiology of metastases in neuroendocrine tumors.Identification and survival outcomes of a cohort of patients with cancer of unknown primary in Ontario, Canada.Site-specific cancer deaths in cancer of unknown primary diagnosed with lymph node metastasis may reveal hidden primaries.The challenge of attributing causality in cancer of unknown primary.Global microRNA profiling in favorable prognosis subgroups of cancer of unknown primary (CUP) demonstrates no significant expression differences with metastases of matched known primary tumors.Site-specific survival rates for cancer of unknown primary according to location of metastases.SEOM clinical guideline on unknown primary cancer (2017).Prognostic impact of presumed breast or ovarian cancer among patients with unfavorable-subset cancer of unknown primary site.Diagnostic work-up of carcinoma of unknown primary: from immunohistochemistry to molecular profiling.Molecular Diagnostics in Clinical OncologySurvival outcome differences based on treatments used and knowledge of the primary tumour site for patients with cancer of unknown and known primary in Ontario
P2860
Q21245496-D748FFC3-441F-47A0-92EE-A93EC12ECB88Q26823666-0D166479-6AFC-45CC-82C0-4773EA8B6F1AQ30652409-0697EE23-4E45-41EA-81CE-7E6B76CE1CDEQ34565458-92C58328-D3F3-433D-9823-02A6120A8C01Q34768554-8729AF9A-B45B-494A-82B0-0717FEA82DF0Q36051505-91B0C74E-4410-4818-B66E-9F3C68560409Q36085978-CB4F9A29-BE31-4274-96C9-CBDDB1BD2E49Q36103240-2A06A02C-5EFF-4F53-88ED-73786877902DQ36224208-8EC1CBC9-D076-49ED-A0BB-0DA1CF15510FQ36724760-8AF7D7B6-993D-45DA-B781-ECF9628A411CQ37185727-26EA00EB-4FBA-44CC-89BB-265F9C97F1D9Q37225491-2530FC13-7FAF-43B3-B45A-B06195F7F46EQ37383599-F0C7BCDF-6B07-475A-BD92-753DF1C61E64Q37607002-F6CE2773-E260-4C37-B0D9-CFC250FF2F9CQ37624209-E75A5C3A-44E0-4C4C-8627-4C7576457FABQ38163463-BF845784-BFD9-4E23-92CB-8348F42F8665Q38652049-CC140DAF-6333-4B95-805A-AE915986B414Q38976463-71489270-ABA0-4ACD-9388-06D20FF8F44DQ39885004-5D94AC0C-59ED-4688-A092-220FCE6C02A6Q40610317-40B3C520-72B3-48AA-B833-74FFC8DCE16DQ41136401-8E660BE7-903D-40B0-AB43-97B12A97DE61Q44606549-45D03EA6-F5C2-4D47-A413-4E55932944A1Q44670742-11AEA6BE-E367-48FD-B421-ADE95BA941C7Q46046685-0DEA49B7-7D8A-46E9-A006-E4E432653844Q46282023-10DDC847-69EE-441C-A937-18446C468107Q48136792-3227FC6C-50E6-4BD6-B187-41059EE9EE06Q49578351-82235EE7-6E09-400E-A56C-8F209184A1EBQ51320597-5632E96C-6791-4D11-86F2-24767D59EFB1Q58700723-55EA4163-4744-4415-AAA7-6297DFA45C9DQ59135396-898F0582-17B9-4C2E-A5A5-D0B57F021980
P2860
Cancer of unknown primary: progress in the search for improved and rapid diagnosis leading toward superior patient outcomes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cancer of unknown primary: pro ...... ard superior patient outcomes.
@en
Cancer of unknown primary: pro ...... ard superior patient outcomes.
@nl
type
label
Cancer of unknown primary: pro ...... ard superior patient outcomes.
@en
Cancer of unknown primary: pro ...... ard superior patient outcomes.
@nl
prefLabel
Cancer of unknown primary: pro ...... ard superior patient outcomes.
@en
Cancer of unknown primary: pro ...... ard superior patient outcomes.
@nl
P2093
P2860
P356
P1433
P1476
Cancer of unknown primary: pro ...... ward superior patient outcomes
@en
P2093
G Varadhachary
J Bridgewater
M Erlander
P2860
P304
P356
10.1093/ANNONC/MDR306
P50
P577
2011-06-27T00:00:00Z